semaglutide approval for mash ๐ดWe now have two FDA-approved drugs MASLD/MASH: ๐ธ Resmetirom (oral, THR-ฮฒ agonist) ๐น (weekly SC, GLP-1 RA) side-by-side comparison, courtesy of @rabataller #MASLD #MASH #FattyLiver @_ILTS_ @EASLedu @AASLDtweets @novonordisk Semaglutide as a MASH Treatment:
Description
For someone weighing 220 pounds, 15% weight loss means losing approximately 33 pounds over about 16 months

People using pharmaceutical GLP-1 drugs who want microbiome support alongside their medication

Patients losing substantial weight while on semaglutide may experience shifts in levothyroxine dosing needssometimes requiring lower doses as metabolism adjusts

2017;5 doi: 10.14814/phy2.13102
The RLU value is positively associated with the concentration of Human GLP-1

Available at: 2025 Novo Nordisk All rights reserved
